Share
Excellent news!
Roolife did a great job with Trilogy in China, and seems to have expertise in navigating the complexities of the 'regulatory' environment there for health and pharma products.
Chinese demand for proven nutrition and healthcare products is almost insatiable. Growing middle class, ageing population, increased global integration and awareness, growing acceptance of non-traditional medicines... Look at how a well executed Chinese entry has changed the fortunes of companies like A2M, Blackmores (and more recently Entity Health), many of New Zealand's manuka businesses (bar Comvita, which has major structural issues)...
Let's just hope that our supply chain can keep pace.
